摘要
目的:构建并鉴定含人OX40-IgG1融合基因的重组腺病毒载体,并感染人肝HL-7702细胞,筛选出最佳感染剂量并检测OX40Ig的表达情况,为进一步用于器官移植后的抗排斥治疗奠定基础。方法:根据基因库公布的人OX40和hIgG1 Fc片断序列设计特定引物,通过聚合酶链反应扩增并鉴定后,酶切插入穿梭质粒pAdTrack-CMV中。随后与pAdeasy-1腺病毒质粒以氯化钙法共转化BJ5183感受态细胞,重组质粒经鉴定正确后,大量扩增为腺病毒载体。再经293A细胞包装、扩增并纯化后感染HL-7702肝细胞,筛选出最佳感染剂量,并采用间接免疫荧光法检测其中外源性OX40Ig基因的表达,采用ELISA法测定肝HL-7702细胞上清中OX40Ig蛋白的含量。结果:转移质粒pTOX40Ig经酶切及测序鉴定正确。重组腺病毒质粒经酶切鉴定正确,并成功转染了293A细胞。得到的病毒液经纯化扩增后进一步感染肝HL-7702细胞,经筛选,10 MOI为最佳感染剂量,并且可以检测到OX40Ig目的基因及其蛋白的表达。结论:成功构建了重组腺病毒载体AdOX40Ig,并且可在肝细胞HL-7702中表达相应的目的基因及蛋白。
Objective: To construct and identify recombinant adenovirus vector containing the human OX40-IgG1 fusion gene,then to infect the HL-7702 liver cells to filter out the best infective dose and detect expression of OX40Ig,which lay a foundation for the immune therapy inhibitory after organ transplantation.Methods: Specific OX40 and hIgG1 Fc primers were designed according to GenBank,and subcloned into the pAdTrack-CMV shuttle plasmid after PCR and identification.Retransformed into BJ5183 competent cells with pAdeasy-1 by calcium chloride method.The recombinant plasmid was detected by PCR and DNA sequence analysis and was transfected into 293A cells.The recombinant adenovirus infected HL-7702 liver cells and filtered out the best infective dose.OX40Ig gene expression was detected by indirect immunofluorescence assay.OX40Ig protein expression was detected by ELISA.Results:pTOX40Ig and pAdOX40Ig were constructed successfully according to restriction endonuclease analysis.293A cells were transfected,and then the purified recombinant adenovirus infected HL-7702 liver cells.10 MOI was the best infective dose.OX40Ig effective expression was detected in HL-7702 liver cells.Conclusion: The recombinant adenovirus vector AdOX40Ig carrying the human OX40-IgG1 fusion gene was successfully constructed,and OX40Ig effective expression was found in HL-7702 liver cells in vitro.
出处
《江苏大学学报(医学版)》
CAS
2013年第1期12-16,共5页
Journal of Jiangsu University:Medicine Edition
基金
镇江市社会发展计划资助项目(SH2006042)
江苏大学高级人才启动基金资助项目(11JGD0090)